DOCSLIB.ORG

Modulation of Cell Surface Protein Expression by Infection with HIV-1 C Speth and MP Dierich

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Modulation of Cell Surface Protein Expression by Infection with HIV-1 C Speth and MP Dierich Leukemia (1999) 13, Suppl. 1, S99–S105 1999 Stockton Press All rights reserved 0887-6924/99 $12.00 http://www.stockton-press.co.uk/leu Modulation of cell surface protein expression by infection with HIV-1 C Speth and MP Dierich Institute for Hygiene and Ludwig-Boltzmann-Institute for AIDS Research, Innsbruck. Austria Keywords: HIV; protein expression; costimulation; complement; The modulation of several cell surface molecules by HIV-1 adhesion; apoptosis as described in the literature is summarized in Table 1. The list includes: (1) certain molecules involved in immune acti- vation eg B7, CD7, MHC class I and II and CD4; (2) comp- Introduction lement-related proteins like complement receptors and nega- tive regulators of complement activation; (3) various cell The infection of several cell types by the human immunodefi- adhesion molecules; (4) Fas and FasL as apoptosis-related pro- ciency virus (HIV-1) has profound effects on the surface pro- teins; and (5) receptors for important immune regulatory cyto- tein pattern of the host cell. Expression of a variety of cell kines. For some of these surface molecules the viral effector surface molecules is modulated by infection, the most promi- protein responsible for modulatory effect is already known nent being CD4, the coreceptor for MHC class II on helper including the surface molecules gp120 and gp41 and the T cells. regulatory molecules Nef, Tat and Vpu. In this review we will This phenomenon might be biologically relevant in provide a more detailed discussion about some selected several aspects: examples of each group with possible effects of modulated (1) Since HIV-1 is known to acquire a lot of host cell surface expression on HIV-induced pathogenesis and, if known, the molecules during the budding process, upregulation of viral proteins responsible for the modulation. their cell surface expression results in an increased occur- rence on the viral surface. Host cell-derived molecules have at least partly been shown to retain their biological Decreased expression of costimulatory molecules CD28 function on the viral surface and to be involved in pro- and B7 cesses like adhesion of viral particles to potential host cells (eg ICAM-1) or protection of virions against attack by the A complete T cell activation requires both T cell receptor complement system (eg CD55, a negative regulator of (TCR) stimulation and costimulation by accessory molecules. complement activation). Consequently, a high cellular expression of certain membrane molecules is advan- tageous for the progenitor virions budding from this cell. Table 1 Examples for the modulation of cell surface molecules by (2) Alteration of the cell surface protein expression can also infection with HIV-1 modulate functionality of host cells. Important cellular processes of immune cells like migration or lymphocyte Protein family Protein Regulatory HIV Ref. homing depend on the presence of special receptors on protein the cell surface, eg adhesion molecules for blood vessel endothelial cells. Modulation of receptor expression, General HLA-DR gp41; not gp 1,2 therefore, influences viral spreading throughout the body. 120 or p24 CD4 gp120—Nef, 3–7 (3) Modulation of the expression of cellular surface receptors Vpu, Tat may alter susceptibility of the host cells towards cytokines CD7 not gp120 or 2 or intercellular counter-receptors, thereby modulating p24 parameters like cell proliferation, differentiation and, via MHC 1 Vpu, Nef, gp41 8–12 cell activation, viral replication. B7 (CD80, 13 (4) Since an altered cytokine synthesis is involved in HIV- CD86) CD16 13 induced pathogenesis several therapy attempts aim to CD3 14 restore the normal cytokine level by an external addition CD28 15,16 of cytokines. Many therapeutical approaches include Complement-related CR1 17,18 external addition of interleukine 2 (IL-2) to re-activate the proteins immune response against viral infection. Altered levels of CR2 19,20 cytokine receptors is one possible reason for therapy fail- CR3 21 C5aR 22 ure in some cases. CD55 (Daf) 21,23 (5) Downmodulation of host cell surface receptors (eg CD28, Adhesion molecules LFA-1 (CD1 not gp120, p24 2 MHC class I) might reduce immune cell activation as a la/CD18) protection mechanism for viral particles and virus-infected VLA-5 Tat 24 cells, thereby contributing to the disturbed immune status CD62L 25 of the organism and the occurrence of secondary infec- CR3 21 Apoptosis-related Fas Tat, gp120 26–28 tions in the late stage of disease. proteins (6) Alteration of the cell surface protein expression could also FasL 29–31 alter the sensitivity of virus-infected cells towards apop- Cytokine receptors IL-2R Tat, gp120, nef 32–34 totic signals and support or inhibit the elimination of virus- TNF receptor Tat 35 infected cells, thereby being an important parameter for IL-4R Tat 36 viral pathogenesis. Abstracts S100 The CD28 receptor on CD4+ and CD8+ T cells interacts with and/or C4b. CR1 on erythrocytes enables these cells to trans- B7 molecules on antigen-presenting cells (APC) to generate port opsonized immune complexes to phagocytic cells in liver those essential costimulatory signals. B7 includes two func- and spleen, where the immune complexes are removed from tionally related costimulatory molecules, B7–1 (CD80) and the erythrocytic surface and engulfed by the phagocytes.42 B7–2 (CD86). Costimulation results in cytokine production, T Moreover, CR1 is a negative regulatory protein of complement cell proliferation and activation of cytotoxicity. cascade activation with cofactor activity for factor I-mediated During the progression of AIDS disease CD28 expression is cleavage of C3b and C4b into inactive fragments. CR1 also lost on CD4+ and CD8+ T cells.37 This loss is correlated with has decay-accelerating activity for the C3 convertase of both reduced responsiveness to costimulation suggesting that dys- the classical and the alternative complement activation regulation of normal T cell function associated with HIV-1 pathway.43,44 infection may partly result from the loss of CD28 expression. B cells isolated from HIV-infected persons express signifi- On CD8+ T cells from HIV+ subjects the disease stage-related cantly reduced levels of surface CR1 when compared with B reduction in CD28 expression was rather strong and associa- cells derived from control donors.18 This down-modulation of ted with significantly reduced proliferative response to complement receptor I may have some effects on the ability costimulation with cell-bound anti-CD3 and B7. CD4+ T cells of B cells to capture and engulf opsonized antigens for presen- from the patients showed a slighter but nevertheless significant tation to T cells. The decrease in complement receptor level CD28 down-regulation and were also hyporesponsive to B7 in late stages of disease could thus be one factor adding to co-stimulation.38 the immune dysfunction of T cells. In addition, lack of the Not only CD28 but also the ligand B7 shows an altered negative regulator molecule CR1 of the complement system expression after HIV infection. Patient-derived macrophages may contribute to increased complement activation observed express B7 molecules in a lower density than macrophages in HIV patients. derived from healthy donors.13 Monocytes that express consti- On erythrocytes the number of CR1 surface molecules is tutively B7 lose this marker after HIV-1 infection and become also significantly decreased in symptomatic HIV-infected indi- refractory to inducers of B7 synthesis.39 This down-modu- viduals correlating with increasing levels of circulating lation is an indirect effect mediated by an altered IL-10 pro- immune complexes and with the clinical severity of dis- duction since B7 expression can be normalized by the incu- ease.45,46 Since reduced CR1 expression on erythrocytes has bation of patient macrophages with anti-IL-10 monoclonal been associated with autoimmune diseases HIV-mediated antibodies.13 The decreased expression of CD28 and B7 mol- down-modulation of CR1 on erythrocytes in HIV patients ecules on T lymphocytes and macrophages is a critical para- could also contribute to the increase of autoantibody presence meter for immune dysfunction and disease progression. noticed in infected individuals.46 Since costimulation is crucial for immune activation also Additional studies on erythrocytes indicated that modu- novel vaccination protocols have been developed to induce lation of CR1 expression on those infected cells is achieved HIV-1 antigen-specific immune responses by DNA vacci- by enhanced proteolytic cleavage of the surface receptor.17 nation. Coimmunization of CD86 and CD80 expression plas- The CR1 molecule is sensitive against proteolytic attack and mids along with plasmid DNA harboring the genes for HIV-1 CR1 fragments are found on normal erythrocytes as well. The antigen induced a dramatic increase in cytotoxic T lympho- relative amount of these fragments is increased on erythro- cyte induction and CD4+ proliferation when compared with cytes derived from AIDS patients. The mechanism for CR1 HIV antigen immunization alone.40 This stimulating effect is decrease on B cells is as yet unknown as well as the mech- mediated mainly by CD86 expression and can be decreased anism of protease activation by viral infection. by combination with an inhibitor of B7/CD28 costimu- 40,41 lation. The approach represents a new immunization strat- The complement receptor type 2 (CR2) agy to achieve a significant enhancement of the antigen- specific cellular immune response. Complement
Load more

Recommended publications
  • Costimulation of T-Cell Activation and Virus Production by B7 Antigen on Activated CD4+ T Cells from Human Immunodeficiency Virus Type 1-Infected Donors OMAR K
    Proc. Natl. Acad. Sci. USA Vol. 90, pp. 11094-11098, December 1993 Immunology Costimulation of T-cell activation and virus production by B7 antigen on activated CD4+ T cells from human immunodeficiency virus type 1-infected donors OMAR K. HAFFAR, MOLLY D. SMITHGALL, JEFFREY BRADSHAW, BILL BRADY, NITIN K. DAMLE*, AND PETER S. LINSLEY Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, WA 98121 Communicated by Leon E. Rosenberg, August 3, 1993 (receivedfor review April 29, 1993) ABSTRACT Infection with the human immunodeficiency sequence (CTLA-4) (34), a protein structurally related to virus type 1 (HIV-1) requires T-cefl activation. Recent studies CD28 but only expressed on T cells after activation (12). have shown that interactions of the T-lymphocyte receptors CTLA-4 acts cooperatively with CD28 to bind B7 and deliver CD28 and CTLA-4 with their counter receptor, B7, on antigen- T-cell costimulatory signals (13). presenting cells are required for optimal T-cell activation. Here Because of the importance of the CD28/CTLA-4 and B7 we show that HIV-1 infection is associated with decreased interactions in immune responses, it is likely that these expression of CD28 and increased expression of B7 on CD4+ interactions are also important during HIV-1 infection. Stud- T-cell lines generated from seropositive donors by afloantigen ies with anti-CD28 monoclonal antibodies (mAbs) suggested stimulation. Loss of CD28 expression was not seen on CD4+ a role for CD28 in up-regulating HIV-1 long terminal repeat- T-ceU lines from seronegative donors, but up-regulation of B7 driven transcription of a reporter gene in leukemic cell lines expression was observed upon more prolonged culture.
    [Show full text]
  • Natural Killer Cells and Current Applications of Chimeric Antigen Receptor-Modified NK-92 Cells in Tumor Immunotherapy
    International Journal of Molecular Sciences Review Natural Killer Cells and Current Applications of Chimeric Antigen Receptor-Modified NK-92 Cells in Tumor Immunotherapy Jianguang Zhang, Huifang Zheng and Yong Diao * School of Medicine, Huaqiao University, Quanzhou 362021, Fujian, China; [email protected] (J.Z.); [email protected] (H.Z.) * Correspondence: [email protected]; Tel.: +86-595-2269-2516 Received: 15 November 2018; Accepted: 11 January 2019; Published: 14 January 2019 Abstract: Natural killer (NK) cells are innate immune cells that can be activated rapidly to target abnormal and virus-infected cells without prior sensitization. With significant advancements in cell biology technologies, many NK cell lines have been established. Among these cell lines, NK-92 cells are not only the most widely used but have also been approved for clinical applications. Additionally, chimeric antigen receptor-modified NK-92 cells (CAR-NK-92 cells) have shown strong antitumor effects. In this review, we summarize established human NK cell lines and their biological characteristics, and highlight the applications of NK-92 cells and CAR-NK-92 cells in tumor immunotherapy. Keywords: natural killer cell line; NK-92; chimeric antigen receptor; immunotherapy; tumor 1. Introduction Natural killer (NK) cells are innate immune cells that were first discovered in mice in 1975 [1]. NK cells account for approximately 10% of lymphocytes in human peripheral blood (PB). Owing to the distinct chemokine receptors expressed in NK cells, the distributions of NK cells differ among healthy tissues. Most NK cells are found in the PB, liver, spleen, and bone marrow, and a small portion are also present in the lymph nodes [2–5].
    [Show full text]
  • Expression of the Hematopoietic Stem Cell Antigen CD34 on Blood and Bone Marrow Monoclonal Plasma Cells from Patients with Multiple Myeloma
    Bone Marrow Transplantation, (1997) 19, 553–556 1997 Stockton Press All rights reserved 0268–3369/97 $12.00 Expression of the hematopoietic stem cell antigen CD34 on blood and bone marrow monoclonal plasma cells from patients with multiple myeloma T Kimlinger1 and TE Witzig2 1Department of Laboratory Medicine and 2Division of Internal Medicine and Hematology, Mayo Clinic and Mayo Foundation, Rochester, MN, USA Summary: led to strategies to deplete the tumor cells from the harvest product prior to reinfusion of the stem cells. Monoclonal plasma cells (CD38+CD45−/dim) are typi- One of the current attempts at purifying the harvest pro- cally present in the blood of patients with active mye- duct uses antibody to the CD34 antigen to positively select loma and can contaminate stem cell harvests. This has and enrich hematopoietic stem cells and in the process led to strategies that select CD34+ cells for use in auto- purge the stem cell product of tumor cells and T cells.11–13 logous stem cell transplantation with the goal of The CD34 antigen identifies a lymphohematopoietic stem decreasing tumor cell contamination. The aim of this cell, is present on 1–5% of adult bone marrow cells, and study was to learn if the CD34 antigen is expressed on is expressed on early B cells. The characteristics of this monoclonal plasma cells in the blood or marrow of important antigen and its clinical relevance have recently patients with multiple myeloma. We used three-color been reviewed.14 CD34+ hematopoietic cells from blood or flow cytometry (surface CD38;CD45 and cytoplasmic marrow can reconstitute hematopoiesis after high-dose kappa or lambda) to identify monoclonal plasma cells therapy programs.15 The number of CD34+ cells reinfused in the blood (n = 24) and marrow (n = 37) from patients predicts the time to engraftment.16,17 with plasma cell proliferative disorders.
    [Show full text]
  • MUC1 Is a Potential Target for the Treatment of Acute Myeloid Leukemia Stem Cells
    Published OnlineFirst July 18, 2013; DOI: 10.1158/0008-5472.CAN-13-0677 Cancer Tumor and Stem Cell Biology Research MUC1 Is a Potential Target for the Treatment of Acute Myeloid Leukemia Stem Cells Dina Stroopinsky1, Jacalyn Rosenblatt1, Keisuke Ito1, Heidi Mills1, Li Yin2, Hasan Rajabi2, Baldev Vasir2, Turner Kufe1, Katarina Luptakova1, Jon Arnason1, Caterina Nardella1, James D. Levine1, Robin M. Joyce1, Ilene Galinsky2, Yoram Reiter3, Richard M. Stone2, Pier Paolo Pandolfi1, Donald Kufe2, and David Avigan1 Abstract Acute myeloid leukemia (AML) is a malignancy of stem cells with an unlimited capacity for self-renewal. MUC1 is a secreted, oncogenic mucin that is expressed aberrantly in AML blasts, but its potential uses to target AML þ À stem cells have not been explored. Here, we report that MUC1 is highly expressed on AML CD34 /lineage / À CD38 cells as compared with their normal stem cell counterparts. MUC1 expression was not restricted to AML þ À CD34 populations as similar results were obtained with leukemic cells from patients with CD34 disease. Engraftment of AML stem cell populations that highly express MUC1 (MUC1high) led to development of leukemia in NOD-SCID IL2Rgammanull (NSG) immunodeficient mice. In contrast, MUC1low cell populations established normal hematopoiesis in the NSG model. Functional blockade of the oncogenic MUC1-C subunit with the peptide inhibitor GO-203 depleted established AML in vivo, but did not affect engraftment of normal hematopoietic cells. Our results establish that MUC1 is highly expressed in AML stem cells and they define the MUC1-C subunit as a valid target for their therapeutic eradication.
    [Show full text]
  • Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse
    Welcome to More Choice CD Marker Handbook For more information, please visit: Human bdbiosciences.com/eu/go/humancdmarkers Mouse bdbiosciences.com/eu/go/mousecdmarkers Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse CD3 CD3 CD (cluster of differentiation) molecules are cell surface markers T Cell CD4 CD4 useful for the identification and characterization of leukocytes. The CD CD8 CD8 nomenclature was developed and is maintained through the HLDA (Human Leukocyte Differentiation Antigens) workshop started in 1982. CD45R/B220 CD19 CD19 The goal is to provide standardization of monoclonal antibodies to B Cell CD20 CD22 (B cell activation marker) human antigens across laboratories. To characterize or “workshop” the antibodies, multiple laboratories carry out blind analyses of antibodies. These results independently validate antibody specificity. CD11c CD11c Dendritic Cell CD123 CD123 While the CD nomenclature has been developed for use with human antigens, it is applied to corresponding mouse antigens as well as antigens from other species. However, the mouse and other species NK Cell CD56 CD335 (NKp46) antibodies are not tested by HLDA. Human CD markers were reviewed by the HLDA. New CD markers Stem Cell/ CD34 CD34 were established at the HLDA9 meeting held in Barcelona in 2010. For Precursor hematopoetic stem cell only hematopoetic stem cell only additional information and CD markers please visit www.hcdm.org. Macrophage/ CD14 CD11b/ Mac-1 Monocyte CD33 Ly-71 (F4/80) CD66b Granulocyte CD66b Gr-1/Ly6G Ly6C CD41 CD41 CD61 (Integrin b3) CD61 Platelet CD9 CD62 CD62P (activated platelets) CD235a CD235a Erythrocyte Ter-119 CD146 MECA-32 CD106 CD146 Endothelial Cell CD31 CD62E (activated endothelial cells) Epithelial Cell CD236 CD326 (EPCAM1) For Research Use Only.
    [Show full text]
  • T-Cell Antigen CD28 Mediates Adhesion with B Cells by Interacting with Activation Antigen B7/BB-1 PETER S
    Proc. Nati. Acad. Sci. USA Vol. 87, pp. 5031-5035, July 1990 Immunology T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1 PETER S. LINSLEY*, EDWARD A. CLARKt, AND JEFFREY A. LEDBETTER* *Oncogen, 3005 First Avenue, Seattle, WA 98121; and tDepartment of Microbiology, University of Washington, Seattle, WA 98195 Communicated by Seymour J. Klebanoff, March 30, 1990 ABSTRACT Studies using monoclonal antibodies (mAbs) intercellular adhesion mediated by major histocompatibility have implicated the homodimeric glycoprotein CD28 as an complex (MHC) class I (13) and class II (14) molecules with important regulator of human T-cell activation, in part by the CD8 and CD4 accessory molecules, respectively. We posttranscriptional control ofcytokine mRNA levels. Although have expressed the CD28 antigen to high levels in Chinese the CD28 antigen has functional and structural characteristics hamster ovary (CHO) cells and have used these transfected of a receptor, a natural ligand for this molecule has not been cells to develop a CD28-mediated cell adhesion assay. By identified. Here we show that the CD28 antigen, expressed in using this assay as a screening method, we have demon- Chinese hamster ovary (CHO) cells, mediated specific inter- strated an interaction between CD28 and a natural ligand cellular adhesion with human lymphoblastoid and leukemic expressed on activated B lymphocytes, the B7/BB-1 antigen. B-cell lines and with activated primary murine B cells. CD28- mediated adhesion was not, dependant upon divalent cations. Several mAbs were identified that inhibited CD28-mediated MATERIALS AND METHODS adhesion, including mAb BB-1 against the B-cell activation mAbs.
    [Show full text]
  • T Cells the Usual Subsets
    T cells: the usual subsets Chen Dong and Gustavo J. Martinez T cells have important roles in immune responses and function by directly secreting soluble mediators or important for adaptation of immune responses in different microenvironments and might be particularly through cell contact-dependent mechanisms. Many T cell subsets have been characterized. Although relevant for host defence against pathogens that colonize different tissues. Distinct T cell subsets, or effector T cells were originally considered to be terminally differentiated, a growing body of evidence has differentiation states, can be identified based on the cell surface markers expressed and/or the effector challenged this view and suggested that the phenotype of effector T cells is not completely fixed but is molecules produced by a particular T cell population. This Poster summarizes our current understanding of more flexible or plastic. T cells can have ‘mixed’ phenotypes (that is, have characteristics usually the surface markers, transcriptional regulators, effector molecules and functions of the different T cell associated with more than one T cell subset) and can interconvert from one subset phenotype to another, subsets that participate in immune responses. Further knowledge of how these T cell subsets are regulated IMMUNOLOGY although instructive signalling can lead to long-term fixation of cytokine memory. T cell plasticity can be and cooperate with each other will provide us with better tools to treat immune-related diseases. Cytotoxic T cell Exhausted T cell
    [Show full text]
  • Review of Dendritic Cells, Their Role in Clinical Immunology, and Distribution in Various Animal Species
    International Journal of Molecular Sciences Review Review of Dendritic Cells, Their Role in Clinical Immunology, and Distribution in Various Animal Species Mohammed Yusuf Zanna 1 , Abd Rahaman Yasmin 1,2,* , Abdul Rahman Omar 2,3 , Siti Suri Arshad 3, Abdul Razak Mariatulqabtiah 2,4 , Saulol Hamid Nur-Fazila 3 and Md Isa Nur Mahiza 3 1 Department of Veterinary Laboratory Diagnosis, Faculty of Veterinary Medicine, Universiti Putra Malaysia (UPM), Serdang 43400, Selangor, Malaysia; [email protected] 2 Laboratory of Vaccines and Biomolecules, Institute of Bioscience, Universiti Putra Malaysia (UPM), Serdang 43400, Selangor, Malaysia; [email protected] (A.R.O.); [email protected] (A.R.M.) 3 Department of Veterinary Pathology and Microbiology, Faculty of Veterinary Medicine, Universiti Putra Malaysia (UPM), Serdang 43400, Selangor, Malaysia; [email protected] (S.S.A.); [email protected] (S.H.N.-F.); [email protected] (M.I.N.M.) 4 Department of Cell and Molecular Biology, Faculty of Biotechnology and Biomolecular Science, Universiti Putra Malaysia (UPM), Serdang 43400, Selangor, Malaysia * Correspondence: [email protected]; Tel.: +603-8609-3473 or +601-7353-7341 Abstract: Dendritic cells (DCs) are cells derived from the hematopoietic stem cells (HSCs) of the bone marrow and form a widely distributed cellular system throughout the body. They are the most effi- cient, potent, and professional antigen-presenting cells (APCs) of the immune system, inducing and dispersing a primary immune response by the activation of naïve T-cells, and playing an important role in the induction and maintenance of immune tolerance under homeostatic conditions. Thus, this Citation: Zanna, M.Y.; Yasmin, A.R.; review has elucidated the general aspects of DCs as well as the current dynamic perspectives and Omar, A.R.; Arshad, S.S.; distribution of DCs in humans and in various species of animals that includes mouse, rat, birds, dog, Mariatulqabtiah, A.R.; Nur-Fazila, cat, horse, cattle, sheep, pig, and non-human primates.
    [Show full text]
  • CD2 Molecules Redistribute to the Uropod During T Cell Scanning: Implications for Cellular Activation and Immune Surveillance
    CD2 molecules redistribute to the uropod during T cell scanning: Implications for cellular activation and immune surveillance Elena V. Tibaldi*†, Ravi Salgia†‡, and Ellis L. Reinherz*†§ *Laboratory of Immunobiology and ‡Division of Adult Oncology, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, and †Department of Medicine, Harvard Medical School, Boston, MA 02115 Communicated by Stuart F. Schlossman, Dana-Farber Cancer Institute, Boston, MA, April 9, 2002 (received for review February 14, 2002) Dynamic binding between CD2 and CD58 counter-receptors on op- cells, whereas its counter-receptor CD58 is expressed on a posing cells optimizes immune recognition through stabilization of diverse array of nucleated and non-nucleated cells including cell–cell contact and juxtaposition of surface membranes at a distance APCs and stromal cells (reviewed in refs. 11 and 12). CD2 suitable for T cell receptor–ligand interaction. Digitized time-lapse functions in both T cell adhesion and activation processes (13). Ϸ differential interference contrast and immunofluorescence micros- Of note, the weak affinity of the CD2-CD58 interaction (Kd copy on living cells now show that this binding also induces T cell 1 ␮M) is associated with remarkably fast on and off rates that polarization. Moreover, CD2 can facilitate motility of T cells along foster rapid and extensive exchange between CD2 and CD58 antigen-presenting cells via a movement referred to as scanning. Both partners on opposing cell surfaces (14–16). These biophysical activated CD4 and CD8 T cells are able to scan antigen-presenting cells characteristics are reminiscent of the selectin–ligand interactions surfaces in the absence of cognate antigen.
    [Show full text]
  • And Heterodimeric Interactions Between the Gene Products of PKD1 and PKD2 (Polycystic Kidney Disease͞yeast Two-Hybrid System͞protein–Protein Interactions)
    Proc. Natl. Acad. Sci. USA Vol. 94, pp. 6965–6970, June 1997 Medical Sciences Homo- and heterodimeric interactions between the gene products of PKD1 and PKD2 (polycystic kidney diseaseyyeast two-hybrid systemyprotein–protein interactions) LEONIDAS TSIOKAS*†,EMILY KIM†‡,THIERRY ARNOULD*, VIKAS P. SUKHATME*, AND GERD WALZ*§ *Renal Division, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215; and ‡Laboratory of Molecular and Developmental Neuroscience, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114 Communicated by Irving M. London, Massachusetts Institute of Technology, Cambridge, MA, May 1, 1997 (received for review January 3, 1997) ABSTRACT PKD1 and PKD2 are two recently identified clarified the nature of the aberrant gene products caused by genes that are responsible for the vast majority of autosomal mutations of PKD1 and PKD2. Renal cysts are thought to arise polycystic kidney disease, a common inherited disease that through a process of persistent epithelial proliferation related causes progressive renal failure. PKD1 encodes polycystin, a to the lack of terminal differentiation. Both abnormal growth large glycoprotein that contains several extracellular motifs factor responsiveness (8–12) and the elevated expression of indicative of a role in cell–cell or cell–matrix interactions, and certain oncogenes appear to support this hypothesis (13–16). the PKD2 encodes a protein with homology to a voltage- Recently, loss of heterozygosity was discovered within a subset activated calcium channel and to PKD1. It is currently un- of cysts for two closely linked polymorphic markers located known how mutations of either protein functionally cause within the PKD1 gene, indicating that cyst formation in autosomal polycystic kidney disease.
    [Show full text]
  • Papers J Clin Pathol: First Published As 10.1136/Jcp.49.7.539 on 1 July 1996
    Clin Pathol 1996;49:539-544 539 Papers J Clin Pathol: first published as 10.1136/jcp.49.7.539 on 1 July 1996. Downloaded from Differential expression of T cell antigens in normal peripheral blood lymphocytes: a quantitative analysis by flow cytometry L Ginaldi, N Farahat, E Matutes, M De Martinis, R Morilla, D Catovsky Abstract diagnosis by comparison with findings in Aims-To obtain reference values of the normal counterparts. level of expression of T cell antigens on ( Clin Pathol 1996;49:539-544) normal lymphocyte subsets in order to disclose differences which could reflect Keywords: flow cytometry, T cell antigens, peripheral their function or maturation stages, or blood lymphocytes. both. Methods-Peripheral blood from 15 healthy donors was processed by flow The most common use of flow cytometry is to cytometry with triple colour analysis. For determine the percent of "positive" or "nega- each sample phycoerythrin (PE) conju- tive" cells for each antigen in different cell gated CD2, CD4, CD5, CD8, and CD56 populations. However, valuable information is monoclonal antibodies were combined lost when the relative intensities of the positive with Cy5-R-phycoerythrin (TC) conju- cells, reflecting antigenic densities, are not considered. A cell population with a well gated CD3 and fluorescein isothiocyanate http://jcp.bmj.com/ (FITC) conjugated CD7; CD2- and defined phenotype, positive for one antigen, CD7-PE were also combined with might be heterogeneous with regard to its level CD3-TC and CD4-FITC. Standard mi- of expression. This may reflect different crobeads with different capacities to bind functional or maturational states, or both, or mouse immunoglobulins were used to identify subpopulations on the basis of the dif- convert the mean fluorescence intensity ferent numbers of molecules of antigen per cell.
    [Show full text]
  • T Lymphocytes + and CD8 +CD4 TCR/CD3 Complex in Immortalized Mature -Deficient Γ Signaling Through A
    Signaling Through a CD3γ-Deficient TCR/CD3 Complex in Immortalized Mature CD4+ and CD8+ T Lymphocytes This information is current as Alberto Pacheco-Castro, David Alvarez-Zapata, Pilar of September 25, 2021. Serrano-Torres and José R. Regueiro J Immunol 1998; 161:3152-3160; ; http://www.jimmunol.org/content/161/6/3152 Downloaded from References This article cites 47 articles, 19 of which you can access for free at: http://www.jimmunol.org/content/161/6/3152.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 25, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 1998 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Signaling Through a CD3g-Deficient TCR/CD3 Complex in Immortalized Mature CD41 and CD81 T Lymphocytes1 Alberto Pacheco-Castro,2 David Alvarez-Zapata,2 Pilar Serrano-Torres, and Jose´R. Regueiro3 The biologic role of each CD3 chain and their relative contribution to the signals transduced through the TCR/CD3 complex and to downstream activation events are still controversial: they may be specialized or redundant.
    [Show full text]